Notice of Establishment of the NIH Clinical Center Research Hospital Board, 34359 [2016-12643]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 104 / Tuesday, May 31, 2016 / Notices
The public meetings on
June 14–16, 2016 will be held at the
U.S. Department of Health and Human
Services, Hubert H. Humphrey Building,
Room 705–A, 200 Independence
Avenue SW., Washington, DC 20024.
The public meeting on June 17, 2016
will be held at the Wilbur J. Cohen
Building, 330 Independence Avenue
SW, Snow Room, #5051, Washington,
DC 20201. Phone: (202) 690–7100.
FOR FURTHER INFORMATION CONTACT:
Substantive program information may
be obtained from Rebecca Hines,
Executive Secretary, NCVHS, National
Center for Health Statistics, Centers for
Disease Control and Prevention, 3311
Toledo Road, Hyattsville, Maryland
20782, telephone (301) 458–4715.
Summaries of meetings and a roster of
committee members are available on the
NCVHS home page of the HHS Web site:
https://www.ncvhs.hhs.gov/, where
further information including an agenda
and information for remote audio access
to the meetings will be posted.
Should you require reasonable
accommodation, please contact the CDC
Office of Equal Employment
Opportunity on (301) 458–4EEO (4336)
as soon as possible.
SUPPLEMENTARY INFORMATION:
Status: Open.
Purpose: At the June 14–15, 2016
meeting the Committee will hear
presentations and hold discussions on
several health data policy topics. The
Committee will receive updates from
the Department, including from the
Office of the National Coordinator and
the Centers for Medicare and Medicaid
Services. The Committee will discuss
and take action on two recommendation
letters stemming from the February 16,
2016 Standards Subcommittee hearing
on the proposed Phase IV Operating
Rules and proposed Attachment
Standard. Findings from the June 2015
Review Committee Hearing on Adopted
Transaction Standards, Operating Rules,
Code Sets and Identifiers also will be
discussed. The Committee will review
the current public health data landscape
with briefings from the National Center
for Health Statistics, U.S. Census Bureau
and CDC’s Center for Surveillance,
Epidemiology, and Laboratory Services.
CMS will provide a briefing on MACRA
and the Merit-Based Incentive Payment
System (MIPS). The Committee will
further review its strategic plan for 2016
and all Subcommittees will report on
work plans and next steps. The
Subcommittee on Privacy,
Confidentiality, and Security will brief
the full Committee on proceedings from
the meeting on De-identification and the
Health Insurance Portability and
sradovich on DSK3TPTVN1PROD with NOTICES
ADDRESSES:
VerDate Sep<11>2014
20:07 May 27, 2016
Jkt 238001
Accountability Act (HIPAA) scheduled
for May 24–25, 2016, and discuss
preliminary findings.
After the plenary session adjourns,
the Work Group on HHS Data Access
and Use will continue strategic
discussions on building a framework for
guiding principles for data access and
use.
Privacy-specific topics will be
addressed during the same week at the
following meeting: The NCVHS Privacy,
Confidentiality and Security
Subcommittee will hold a one day
meeting on June 16, 2016 to review the
state of implementation of current
policies and practices of the Health
Insurance Portability and
Accountability Act (HIPAA) Privacy
Minimum Necessary provisions. The
Subcommittee plans to identify and
discuss issues and challenges that the
industry is facing when addressing this
requirement for potential
recommendations to the HHS Secretary
for policy and practice guidance
addressing compliance with the
‘‘minimum necessary’’ standard.
On June 17th the full Committee will
hold a meeting to explore the current
state of the art associated with the
collection and use of Multipayor claims
data bases. These data bases include
private data bases (sometimes known as
Multi-claims Data Bases) and State
claims data bases referred to as AllPayer Claims Databases (APCDs). The
purpose of this meeting is to highlight
the current state of development,
challenges, issues, and opportunities
faced by these initiatives, engage
stakeholders on key issues, and identify
priority areas and opportunities for
recommendations to the Secretary of
HHS and to the industry.
Dated: May 16, 2016.
James Scanlon,
Deputy Assistant Secretary for Planning and
Evaluation, Office of the Assistant Secretary
for Planning and Evaluation.
[FR Doc. 2016–12160 Filed 5–27–16; 8:45 am]
BILLING CODE 4151–05–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Establishment of the NIH
Clinical Center Research Hospital
Board
Pursuant to the Federal Advisory
Committee Act, as amended (5 U.S.C.
App.), the Director, National Institutes
of Health (NIH) announces the
establishment of the NIH Clinical Center
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
34359
Research Hospital Board (Board) as
authorized by 42 U.S.C. 282(b)(16),
Section 402(b)(16) of the Public Health
Service Act, as amended.
It has been determined that the NH
Clinical Center Research Hospital Board
is in the public interest in connection
with the performance of duties imposed
on the National Institutes of Health by
law, and that these duties can best be
performed through the advice and
counsel of the Board.
Inquiries may be directed to Jennifer
Spaeth, Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail code 4875), Telephone (301) 496–
2123, or spaethj@od.nih.gov .
Dated: May 24, 2016.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–12643 Filed 5–27–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Peer Review Meeting.
Date: June 21–22, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Hilton Washington/Rockville,
Jefferson Room, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Nancy VazquezMaldonado, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of
Extramural Activities, Room 3F52B National
Institutes of Health/NIAID, 5601 Fishers
Lane, MSC 9834, Bethesda, MD 20892–9834,
(240) 669–5044, nvazquez@niaid.nih.gov.
E:\FR\FM\31MYN1.SGM
31MYN1
]]>Agencies
[Federal Register Volume 81, Number 104 (Tuesday, May 31, 2016)]
[Notices]
[Page 34359]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-12643]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Establishment of the NIH Clinical Center Research
Hospital Board
Pursuant to the Federal Advisory Committee Act, as amended (5
U.S.C. App.), the Director, National Institutes of Health (NIH)
announces the establishment of the NIH Clinical Center Research
Hospital Board (Board) as authorized by 42 U.S.C. 282(b)(16), Section
402(b)(16) of the Public Health Service Act, as amended.
It has been determined that the NH Clinical Center Research
Hospital Board is in the public interest in connection with the
performance of duties imposed on the National Institutes of Health by
law, and that these duties can best be performed through the advice and
counsel of the Board.
Inquiries may be directed to Jennifer Spaeth, Director, Office of
Federal Advisory Committee Policy, Office of the Director, National
Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda,
Maryland 20892 (Mail code 4875), Telephone (301) 496-2123, or
spaethj@od.nih.gov .
Dated: May 24, 2016.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-12643 Filed 5-27-16; 8:45 am]
BILLING CODE 4140-01-P
